Robert E. Donohue, MD, presented “Prostate Cancer Screening and Early Detection: Should We Follow the NCCN Guidelines? Con Argument” during the 28th Annual Perspectives in Urology: Point Counterpoint on November 16, 2019 in Scottsdale, Arizona.
How to cite: Donohue, Robert E. “Prostate Cancer Screening and Early Detection: Should We Follow the NCCN Guidelines? Con Argument” November 16, 2019. Accessed Nov 2024. https://prostate-cancer-screening-and-early-detection-should-we-follow-the-nccn-guidelines-con-argument/
Prostate Cancer Screening and Early Detection: Should We Follow the NCCN Guidelines? Con Argument – Summary:
Robert E. Donohue, MD, argues against urologists adhering to the National Comprehensive Cancer Network (NCCN) Prostate Cancer Screening and Early Detection Guidelines. He proposes his own definitive answers to controversial questions relating to the use of digital rectal exams and PSA tests in baseline evaluation, indications for biopsy and biopsy technique, the age for initiation and discontinuation of testing, the frequency of testing, screening in high-risk populations, and which biomarkers to use.
The “pro” rebuttal to this presentation is “Prostate Cancer Screening and Early Detection: Should We Follow the NCCN Guidelines? Pro Argument” by A. Karim Kader, MD, PhD.
About Perspectives in Urology: Point Counterpoint
Perspectives in Urology: Point Counterpoint (PCP) is an annual, multi-day, CME-accredited conference devoted to discussing and debating the latest topics in men’s health and general urology, as well as management of bladder, renal, and both localized and advanced prostate cancer. More than didactic lectures, the conference’s format includes debates, point-counterpoint discussion panels, and unique case-based presentations. Dr. Donohue presented this lecture during the 28th PCP in 2019. Please visit this page in order to register for future PCP meetings.
ABOUT THE AUTHOR
Robert E. Donohue, MD, graduated from the New York University (NYU) School of Medicine and then went on to complete his Surgery and Urology Residency at NYU as well. Dr. Donohue was then appointed Special Fellow in Urology at the Memorial Sloan Kettering Cancer Center in New York City. Spending some time abroad, Dr. Donohue then became the Senior Surgical Registrar in Urology at the Christchurch Public Hospital in Christchurch, New Zealand. Back in the USA, he was appointed Assistant Professor of Surgery for Urology and Director of Medical Student Programs at The University of Colorado in 1972, as well as the Chief of Urology Service at the Denver CAMC in 1977. He was promoted to Associate Professor in 1979 and Full Professor in 1989. As a professor, Dr. Donohue directed urology rotations at the medical school and was appointed Director of the Career Choices Electives in Urology in 2004. He was also Editor of “Classic Articles in Urology” for Urology from 1984-1989. Dr. Donohue was also Chairman of the Rocky Mountain Urological Society from 1975-1988 and President from 1994-1996.
This Brooklyn-born-and-raised doctor retired in 2009. In 2008, Dr. Donohue was appointed Historian of the South Central Section (SCS) of the American Urological Association (AUA) and he continued in that role for several years. Dr. Donohue has devoted a lot of time to the AUA, and especially the SCS of the AUA. He was appointed the representative of the AUA to the Journal of Urology from 1989-1994. Then, in 1998, he was elected Secretary of the SCS, where he served for four years. In 2004, Dr. Donohue was named President of the SCS and his presidential meeting was held jointly with the Irish Urological Society in Dublin, Ireland. Also in 2004, Dr. Donohue was appointed the SCS representative to the AUA Judicial and Ethics Committee and served in that position until 2010.
